208 related articles for article (PubMed ID: 31934812)
1. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
[No Abstract] [Full Text] [Related]
2. Addition of EP2 agonists to an FP agonist additively and synergistically modulates adipogenesis and the physical properties of 3D 3T3-L1 sphenoids.
Ida Y; Watanabe M; Umetsu A; Ohguro H; Hikage F
Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102315. PubMed ID: 34246925
[TBL] [Abstract][Full Text] [Related]
3. Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells.
Ida Y; Hikage F; Umetsu A; Ida H; Ohguro H
Sci Rep; 2020 Sep; 10(1):16018. PubMed ID: 32994409
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Use of ROCK Inhibitors and EP2 Agonists Induces Unexpected Effects on Adipogenesis and the Physical Properties of 3T3-L1 Preadipocytes.
Ida Y; Watanabe M; Ohguro H; Hikage F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925005
[TBL] [Abstract][Full Text] [Related]
5. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy.
Taketani Y; Yamagishi R; Fujishiro T; Igarashi M; Sakata R; Aihara M
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1269-76. PubMed ID: 24508785
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm's canal endothelial cells and ciliary muscle contraction.
Nakamura N; Honjo M; Yamagishi R; Igarashi N; Sakata R; Aihara M
Sci Rep; 2021 Aug; 11(1):16257. PubMed ID: 34376747
[TBL] [Abstract][Full Text] [Related]
7. Glycine enhances expression of adiponectin and IL-10 in 3T3-L1 adipocytes without affecting adipogenesis and lipolysis.
Chen J; Ma X; Yang Y; Dai Z; Wu Z; Wu G
Amino Acids; 2018 May; 50(5):629-640. PubMed ID: 29356901
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.
Choi HY; Lee JE; Lee JW; Park HJ; Lee JE; Jung JH
J Ocul Pharmacol Ther; 2012 Apr; 28(2):146-52. PubMed ID: 22107041
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase.
Khan F; Syeda PK; Nartey MN; Rahman MS; Islam MS; Nishimura K; Jisaka M; Shono F; Yokota K
Prostaglandins Other Lipid Mediat; 2016 Mar; 123():16-27. PubMed ID: 26928048
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.
Ichioka H; Ida Y; Watanabe M; Ohguro H; Hikage F
Exp Eye Res; 2021 Apr; 205():108489. PubMed ID: 33587909
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.
Kirihara T; Taniguchi T; Yamamura K; Iwamura R; Yoneda K; Odani-Kawabata N; Shimazaki A; Matsugi T; Shams N; Zhang JZ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):145-153. PubMed ID: 29332128
[TBL] [Abstract][Full Text] [Related]
12. N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte.
Wang S; Xu Q; Shu G; Wang L; Gao P; Xi Q; Zhang Y; Jiang Q; Zhu X
Biochem Biophys Res Commun; 2015 Oct; 466(3):438-43. PubMed ID: 26365347
[TBL] [Abstract][Full Text] [Related]
13. 6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes.
Tzeng TF; Chang CJ; Liu IM
Phytother Res; 2014 Feb; 28(2):187-92. PubMed ID: 23519881
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
Thyroid; 2013 Dec; 23(12):1600-8. PubMed ID: 24001049
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes.
Chang E; Kim Y
Nutrition; 2016 Jun; 32(6):702-8. PubMed ID: 26899162
[TBL] [Abstract][Full Text] [Related]
16. Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.
Ida Y; Ichioka H; Furuhashi M; Hikage F; Watanabe M; Umetsu A; Ohguro H
Cells; 2021 Nov; 10(11):. PubMed ID: 34831419
[TBL] [Abstract][Full Text] [Related]
17. [Effects of leucine on adipogenesis in 3T3-L1 preadipocytes during and after differentiation].
Yang JT; Xu JY; Jiao J; Zhang R; Han SF; Qin LQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):535-40. PubMed ID: 27256735
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin F2 and EP2 Agonists Exert Different Effects on 3D 3T3-L1 Spheroids during Their Culture Phase.
Ida Y; Furuhashi M; Watanabe M; Umetsu A; Hikage F; Ohguro H
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944637
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study).
Aihara M; Lu F; Kawata H; Tanaka Y; Yamamura K; Odani-Kawabata N; Shams NK
J Ocul Pharmacol Ther; 2019 Dec; 35(10):542-550. PubMed ID: 31674861
[No Abstract] [Full Text] [Related]
20. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.
Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW
Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
